滤泡性甲状腺癌与Hürthle细胞癌:诊断、治疗和临床管理中的挑战
本文综述滤泡性甲状腺癌和Hürthle细胞癌的文献,指出细胞学不确定样本中正确识别癌症具有挑战性且超声特征可能误导,尽管两者有独特表现和预后,但循证指南中无针对滤泡性甲状腺癌和Hürthle细胞癌的具体推荐,应推动该领域进一步研究。
要点
- 滤泡性甲状腺癌是第二常见分化型甲状腺癌,其生物学行为和结局不同于乳头状癌。
- 细胞学不确定样本中正确识别癌症具有挑战性,超声特征可能误导。
- 循证指南中无针对滤泡性甲状腺癌和Hürthle细胞癌的具体推荐,应推动进一步研究。
核心结论
- 尽管滤泡性甲状腺癌和Hürthle细胞癌有独特表现和预后,但循证指南中无针对两者的具体推荐,应推动该领域进一步研究。
研究设计与样本
- 本文为综述,全面回顾滤泡性甲状腺癌文献,旨在提供循证管理指南、揭示指南推荐证据不足并识别诊断、预后和治疗的变化与挑战。
主要发现
- 细胞学不确定样本中正确识别癌症具有挑战性,超声特征可能误导。
- 滤泡性甲状腺癌是第二常见分化型甲状腺癌,其独特生物学行为和较差结局被乳头状甲状腺癌掩盖。
- 循证指南中无针对滤泡性甲状腺癌和Hürthle细胞癌的具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Follicular thyroid cancer is the second most common differentiated thyroid cancer histological type and has been overshadowed by its more common counterpart-papillary thyroid cancer-despite its unique biological behaviour and less favourable outcomes. In this Review, we comprehensively review the literature on follicular thyroid cancer to provide an evidence-based guide to the management of these tumours, to highlight the lack of evidence behind guideline recommendations, and to identify changes and challenges over the past decades in diagnosis, prognosis, and treatment. We highlight that correct identification of cancer in indeterminate cytological samples is challenging and ultrasonographic features can be misleading. Despite certain unique aspects of follicular thyroid cancer presentation and prognosis, no specific recommendations exist for follicular thyroid cancer and Hürthle cell carcinoma in evidence-based guidelines. Efforts should be made to stimulate additional research in this field.
引用
- Grani G, Lamartina L, Durante C, et al. Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol. 2017. PMID: 29102432. doi:10.1016/S2213-8587(17)30325-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。